Pulmonology, Allergy/Immunology, and Sleep Medicine, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Ind.
Pulmonology, Allergy, and Critical Care Medicine, University of Arkansas for Medical Sciences, Little Rock, Ark; Allergy and Immunology, Department of Pediatrics, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Ark; Arkansas Children's Research Institute, Little Rock, Ark.
J Allergy Clin Immunol. 2023 Oct;152(4):827-834. doi: 10.1016/j.jaci.2023.08.008. Epub 2023 Aug 20.
The human microbiome associated with the respiratory tract is diverse, heterogeneous, and dynamic. The diversity and complexity of the microbiome and the interactions between microorganisms, host cells, and the host immune system are complex and multifactorial. Furthermore, the lymphatics provide a direct highway, the gut-lung axis, for the gut microbiome to affect outcomes related to respiratory disease and the host immune response. Viral infections in the airways can also alter the presence or absence of bacterial species, which might increase the risks for allergies and asthma. Viruses infect the airway epithelium and interact with the host to promote inflammatory responses that can trigger a wheezing illness. This immune response may alter the host's immune response to microbes and allergens, leading to T2 inflammation. However, exposure to specific bacteria may also tailor the host's response long before the virus has infected the airway. The frequency of viral infections, age at infection, sampling season, geographic location, population differences, and preexisting composition of the microbiota have all been linked to changes in microbiota diversity and stability. This review aims to evaluate the current reported evidence for microbiome interactions and the influences that viral infection may have on respiratory and gut microbiota, affecting respiratory outcomes in children.
与呼吸道相关的人类微生物组具有多样性、异质性和动态性。微生物组的多样性和复杂性以及微生物、宿主细胞和宿主免疫系统之间的相互作用是复杂的、多因素的。此外,淋巴系统为肠道微生物组提供了一条直接的高速公路,即肠-肺轴,从而影响与呼吸疾病和宿主免疫反应相关的结果。气道中的病毒感染也可以改变细菌种类的存在与否,这可能会增加过敏和哮喘的风险。病毒感染气道上皮细胞并与宿主相互作用,促进炎症反应,从而引发喘息疾病。这种免疫反应可能改变宿主对微生物和过敏原的免疫反应,导致 T2 炎症。然而,在病毒感染气道之前,特定细菌的暴露也可能使宿主的反应具有特异性。病毒感染的频率、感染年龄、采样季节、地理位置、人群差异和预先存在的微生物组组成都与微生物组多样性和稳定性的变化有关。本综述旨在评估目前关于微生物组相互作用的报告证据,以及病毒感染可能对呼吸和肠道微生物组的影响,从而影响儿童的呼吸结局。